theory clinical_47_7
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  PARP :: "entity ⇒ bool"
  DSBs :: "entity ⇒ bool"
  SSBreakRepair :: "entity ⇒ bool"
  Function :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  Prevent :: "event ⇒ bool"
  LeadTo :: "event ⇒ entity ⇒ bool"
  CollapsedReplicationForks :: "entity ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  LossBRCA2 :: "entity ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  GenomicInstability :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Involve :: "event ⇒ bool"
  HRRDefective :: "event ⇒ bool"
  TrappingPARP1 :: "entity ⇒ bool"
  NHEJ :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  Toxicity :: "event ⇒ bool"
  Indicate :: "event ⇒ bool"
  RelyOn :: "event ⇒ entity ⇒ bool"
  NHEJErrorProne :: "entity ⇒ bool"

(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks. *)
axiomatization where
  explanation_1: "∃x y z w e1 e2 e3 e4. PARPInhibitors x ∧ PARP y ∧ DSBs z ∧ SSBreakRepair w ∧ Function e1 ∧ Agent e1 x ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e3 ∧ Agent e3 y ∧ Patient e3 z ∧ Prevent e4 ∧ Agent e4 y ∧ Patient e4 w ∧ LeadTo e4 z ∧ CollapsedReplicationForks z"

(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. LossBRCA2 x ∧ CancerDevelopment y ∧ GenomicInstability z ∧ Drive e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ Involve e2 ∧ Agent e2 z ∧ HRRDefective e2"

(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. TrappingPARP1 x ∧ DSBs y ∧ NHEJ z ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Increase e2 ∧ Agent e2 x ∧ Toxicity e2 ∧ Indicate e3 ∧ Agent e3 x ∧ RelyOn e3 z ∧ NHEJErrorProne z"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DSBs y ∧ SSBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ RelyOn e3 z ∧ HRRDefective e3 ∧ NHEJErrorProne z"
proof -
  (* From the premise, we have the known information about PARP inhibitors. *)
  from asm have "PARPInhibitors x" by simp
  (* There is a logical relation Implies(A, B), Implies(PARP inhibitors function by inhibiting PARP, double-strand breaks occur) *)
  (* A is from explanatory sentence 1, B is from explanatory sentence 1. *)
  (* We can infer double-strand breaks occur. *)
  then have "DSBs y" sledgehammer
  (* There is a logical relation Implies(A, C), Implies(PARP inhibitors function by inhibiting PARP, single-strand break repair is prevented) *)
  (* We can infer single-strand break repair is prevented. *)
  then have "SSBreakRepair z" <ATP>
  (* There is a logical relation Implies(G, H), Implies(genomic instability occurs, defective homologous recombination repair occurs) *)
  (* From explanation 2, we know that genomic instability involves defective homologous recombination repair. *)
  then have "HRRDefective e3" <ATP>
  (* There is a logical relation Implies(I, L), Implies(trapping of PARP1 at sites of double-strand breaks, reliance on error-prone non-homologous end joining for DNA repair) *)
  (* From explanation 3, we know that trapping of PARP1 indicates reliance on error-prone non-homologous end joining. *)
  then have "NHEJErrorProne z" <ATP>
  (* Combine all the inferred information to prove the hypothesis. *)
  then show ?thesis <ATP>
qed

end
